Dr. Alfredo Alonso Poza, head of the General Surgery and Digestive System Service of the University Hospital of the Southeast of Madrid, has expressed in a press release its “concern” about the growing popularity of tirzepatide injections to lose weight, marketed by the brand Mounjaro.
This warning from the surgeon comes after the death of a 58 year old english nursedays after injecting two doses of this medication. The surgeon has stressed the importance of the use of this medication, which has been available to doctors in Spain since last June 2024, always occur. under strict medical control.
According to the death reportthe nurse’s death was due to a “multiorgan failure, septic shock and pancreatitis”. Given this event, Dr. Alonso Poza emphasized that these treatments are designed for specific profiles of patients suffering from obesity and who, in many cases, have already tried other weight control methods without success. “They are not indicated for general use without the supervision of a specialist, since the risks can outweigh the benefits if they are not used correctly,” he warned.
The also surgeon in the Quirón San Camilo Hospital in Madrid emphasized that although these types of injections can offer benefits in controlled cases, improper use can have serious adverse health effects. “The indications must be precise and always under the monitoring of a qualified medical team, who can evaluate not only the benefits, but also the individual risks for each patient,” he stressed.
A medicine that is becoming popular
Dr. Alonso Poza assured that this type of medication “should not be administered to patients who have had a previous pancreatitis and no stones in the gallbladder“. He warned that these injections to treat obesity are becoming popular, but that “it is evident that they cannot be injected in a happy and uncontrolled manner.”
He insisted that these drugs should never be administered without having an analysis and a previous abdominal ultrasound, in addition to having taken the patient’s history and having excluded any previous pancreatitis.
They are not a “quick fix”
With extensive experience in surgery and obesity treatment, Dr. Alonso Poza stressed that these medications are not a “quick fix.” “It is essential to carry out constant medical monitoring to adjust doses and evaluate side effects; only in this way can the risks of adverse reactions be minimized,” he indicated.
Do you want to receive the best content to take care of your health and feel good? Sign up for our new newsletter for free.
#surgeon #warns #danger #tirzepatide #injections #lose #weight #death #nurse
